FAAH-IN-6
FAAH-IN-6 (compound 21d) is a potent, orally active and cross the blood-brain barrier fatty acid amide hydrolase (FAAH) inhibitor with IC50s of 0.72, 0.28 nM for hFAAH, rFAAH, respectively. FAAH-IN-6 shows dose-dependent analgesic efficacy in animal models of both neuropathic and inflammatory pain[1].
Product Specifications
CAS Number
1143578-94-2
UNSPSC
12352005
Target
FAAH
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/faah-in-6.html
Purity
99.70
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N1CCN(C2=NC=CC(C3=CC=C(F)C(F)=C3)=N2)CC1)NC4=NN=CC=C4
Molecular Formula
C19H17F2N7O
Molecular Weight
397.38
References & Citations
[1]Kono M, et al. Design, synthesis, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors. Bioorg Med Chem. 2014 Feb 15;22 (4) :1468-78.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1046041-01 0.02 mg (E-Coli)
Recombinant Staphylococcus aureus Holliday junction resolvase recU (recU)
Sign In for Pricing
View Details MBS1046041-02 0.1 mg (E-Coli)
Recombinant Staphylococcus aureus Holliday junction resolvase recU (recU)
Sign In for Pricing
View Details MBS1046041-03 0.02 mg (Yeast)
Recombinant Staphylococcus aureus Holliday junction resolvase recU (recU)
Sign In for Pricing
View Details